MUC16: Molecular analysis and its functional implications in benign and malignant conditions

FASEB Journal

Volumn 28, Issue 10, 2014, Pages 4183-4199

  Haridas, Dhanya ^a   Ponnusamy, Moorthy P ^a   Chugh, Seema ^a   Lakshmanan, Imayavaramban ^a   Seshacharyulu, Parthasarathy ^a   Batra, Surinder K ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Animal model; Cancer; Domain structure; MUC16

Indexed keywords

ANTIBODY; GLYCOPROTEIN; GLYCOPROTEIN MUC16; UNCLASSIFIED DRUG; CA 125 ANTIGEN; MEMBRANE PROTEIN; MUC16 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; BENIGN TUMOR; BREAST CANCER; EPITHELIUM CELL; GENITAL SYSTEM; HUMAN; INFLAMMATORY BOWEL DISEASE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NOSE; OCULAR SURFACE EPITHELIA; OVARY CANCER; PANCREAS CANCER; PHYLOGENY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; TRACHEA; ANIMAL; GENETICS; METABOLISM; NEOPLASMS;

ANIMALS; CA-125 ANTIGEN; EPITHELIAL CELLS; HUMANS; MEMBRANE PROTEINS; NEOPLASMS;

EID: 84907682726     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-257352     Document Type: Review

References (138)

1. Torres, M. P., Chakraborty, S., Souchek, J., and Batra, S. K. (2012) Mucin-based targeted pancreatic cancer therapy. Curr. Pharm. Des. 18, 2472-2481
2. Rachagani, S., Torres, M. P., Moniaux, N., and Batra, S. K. (2009) Current status of mucins in the diagnosis and therapy of cancer. Biofactors 35, 509-527
3. Moniaux, N., Escande, F., Porchet, N., Aubert, J. P., and Batra, S. K. (2001) Structural organization and classification of the human mucin genes. Front. Biosci. 6, D1192-D1206
4. Byrd, J. C., and Bresalier, R. S. (2004) Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 23, 77-99
5. Rachagani, S., Torres, M. P., Kumar, S., Haridas, D., Baine, M., Macha, M. A., Kaur, S., Ponnusamy, M. P., Dey, P., Seshacharyulu, P., Johansson, S. L., Jain, M., Wagner, K. U., and Batra, S. K. (2012) Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy. J. Hematol. Oncol. 5, 68
6. Bast, R. C., Jr., Feeney, M., Lazarus, H., Nadler, L. M., Colvin, R. B., and Knapp, R. C. (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Invest. 68, 1331-1337
7. Bast, R. C., Jr., Klug, T. L., St, J. E., Jenison, E., Niloff, J. M., Lazarus, H., Berkowitz, R. S., Leavitt, T., Griffiths, C. T., Parker, L., Zurawski, V. R., Jr., and Knapp, R. C. (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N. Engl. J. Med. 309, 883-887
8. Yin, B. W., and Lloyd, K. O. (2001) Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J. Biol. Chem. 276, 27371-27375
9. O'Brien, T. J., Beard, J. B., Underwood, L. J., Dennis, R. A., Santin, A. D., and York, L. (2001) The CA 125 gene: an extracellular superstructure dominated by repeat sequences. Tumor Biol. 22, 348-366
10. Gipson, I. K., and Argueso, P. (2003) Role of mucins in the function of the corneal and conjunctival epithelia. Int. Rev. Cytol. 231, 1-49
11. Argueso, P., Spurr-Michaud, S., Russo, C. L., Tisdale, A., and Gipson, I. K. (2003) MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope. Invest. Ophthalmol. Vis. Sci. 44, 2487-2495
12. Gipson, I. K., Blalock, T., Tisdale, A., Spurr-Michaud, S., Allcorn, S., Stavreus-Evers, A., and Gemzell, K. (2008) MUC16 is lost from the uterodome (pinopode) surface of the receptive human endometrium: in vitro evidence that MUC16 is a barrier to trophoblast adherence. Biol. Reprod. 78, 134-142
13. Tyler, C., Kapur, A., Felder, M., Belisle, J. A., Trautman, C., Gubbels, J. A., Connor, J. P., and Patankar, M. S. (2012) The mucin MUC16 (CA125) binds to NK cells and monocytes from peripheral blood of women with healthy pregnancy and preeclampsia. Am. J. Reprod. Immunol. 68, 28-37
14. Gubbels, J. A., Felder, M., Horibata, S., Belisle, J. A., Kapur, A., Holden, H., Petrie, S., Migneault, M., Rancourt, C., Connor, J. P., and Patankar, M. S. (2010) MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells. Mol. Cancer 9, 11
15. Belisle, J. A., Horibata, S., Jennifer, G. A., Petrie, S., Kapur, A., Andre, S., Gabius, H. J., Rancourt, C., Connor, J., Paulson, J. C., and Patankar, M. S. (2010) Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes. Mol. Cancer 9, 118
16. Huffmeier, U., Lascorz, J., Becker, T., Schurmeier-Horst, F., Magener, A., Ekici, A. B., Endele, S., Thiel, C. T., Thoma- Uszynski, S., Mossner, R., Reich, K., Kurrat, W., Wienker, T. F., Traupe, H., and Reis, A. (2009) Characterisation of psoriasis susceptibility locus 6 (PSORS6) in patients with early onset psoriasis and evidence for interaction with PSORS1. J. Med. Genet. 46, 736-744
17. Caffery, B., Joyce, E., Heynen, M. L., Jones, L., Ritter, R., III, Gamache, D. A., Senchyna, M. (2008) MUC16 expression in Sjogren's syndrome, KCS, and control subjects. Mol. Vis. 14, 2547-2555
18. Ataseven, H., Ozturk, Z. A., Arhan, M., Yuksel, O., Koklu, S., Ibis, M., Basar, O., Yilmaz, F. M., and Yuksel, I. (2009) Cancer antigen 125 levels in inflammatory bowel diseases. J. Clin. Lab. Anal. 23, 244-248
19. Kim, E. S., Park, K. U., Song, J., Lim, H. J., Cho, Y. J., Yoon, H., Lee, J., Lee, C. T., and Park, J. S. (2013) The clinical significance of CA-125 in pulmonary tuberculosis. Tuberculosis (Edinb.) 93, 222-226
20. Haridas, D., Chakraborty, S., Ponnusamy, M. P., Lakshmanan, I., Rachagani, S., Cruz, E., Kumar, S., Das, S., Lele, S. M., Anderson, J. M., Wittel, U. A., Hollingsworth, M. A., and Batra, S. K. (2011) Pathobiological implications of MUC16 expression in pancreatic cancer PLoS One 6, e26839
21. Lakshmanan, I., Ponnusamy, M. P., Das, S., Chakraborty, S., Haridas, D., Mukhopadhyay, P., Lele, S. M., and Batra, S. K. (2012) MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells. Oncogene 31, 805-817
22. Theriault, C., Pinard, M., Comamala, M., Migneault, M., Beaudin, J., Matte, I., Boivin, M., Piche, A., and Rancourt, C. (2011) MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis. Gynecol. Oncol. 121, 434-443
23. Bast, R. C., Jr., Badgwell, D., Lu, Z., Marquez, R., Rosen, D., Liu, J., Baggerly, K. A., Atkinson, E. N., Skates, S., Zhang, Z., Lokshin, A., Menon, U., Jacobs, I., and Lu, K. (2005) New tumor markers: CA125 and beyond. Int. J. Gynecol. Cancer 15(Suppl. 3), 274-281
24. Wilder, J. L., Pavlik, E., Straughn, J. M., Kirby, T., Higgins, R. V., DePriest, P. D., Ueland, F. R., Kryscio, R. J., Whitley, R. J., Nagell, J. (2003) Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation. Gynecol. Oncol. 89, 233-235
25. Wang, F., Ye, Y., Xu, X., Zhou, X., Wang, J., and Chen, X. (2013) CA-125-indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery. J. Ovarian Res. 6, 14
26. Rustin, G. J., van der Burg, M. E., Griffin, C. L., Guthrie, D., Lamont, A., Jayson, G. C., Kristensen, G., Mediola, C., Coens, C., Qian, W., Parmar, M. K., and Swart, A. M. (2010) Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial. Lancet 376, 1155-1163
27. Hattrup, C. L., and Gendler, S. J. (2008) Structure and function of the cell surface (tethered) mucins. Annu. Rev. Physiol. 70, 431-457
28. Yin, B. W., Dnistrian, A., and Lloyd, K. O. (2002) Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene. Int. J. Cancer 98, 737-740
29. O'Brien, T. J., Beard, J. B., Underwood, L. J., and Shigemasa, K. (2002) The CA 125 gene: a newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure. Tumour Biol. 23, 154-169
30. Chaturvedi, P., Singh, A. P., and Batra, S. K. (2008) Structure, evolution, and biology of the MUC4 mucin. FASEB J. 22, 966-981
31. Kohlgraf, K. G., Gawron, A. J., Higashi, M., Meza, J. L., Burdick, M. D., Kitajima, S., Kelly, D. L., Caffrey, T. C., and Hollingsworth, M. A. (2003) Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line. Cancer Res. 63, 5011-5020
32. Bressan, A., Bozzo, F., Maggi, C. A., and Binaschi, M. (2013) OC125, M11 and OV197 epitopes are not uniformly distributed in the tandem-repeat region of CA125 and require the entire SEA domain. Dis. Markers 34, 257-267
33. Govindarajan, B., and Gipson, I. K. (2010) Membrane-tethered mucins have multiple functions on the ocular surface. Exp. Eye Res. 90, 655-663
34. Maeda, T., Inoue, M., Koshiba, S., Yabuki, T., Aoki, M., Nunokawa, E., Seki, E., Matsuda, T., Motoda, Y., Kobayashi, A., Hiroyasu, F., Shirouzu, M., Terada, T., Hayami, N., Ishizuka, Y., Shinya, N., Tatsuguchi, A., Yoshida, M., Hirota, H., Matsuo, Y., Tani, K., Arakawa, T., Carninci, P., Kawai, J., Hayashizaki, Y., Kigawa, T., and Yokoyama, S. (2004) Solution structure of the SEA domain from the murine homologue of ovarian cancer antigen CA125 (MUC16). J. Biol. Chem. 279, 13174-13182
35. Duraisamy, S., Ramasamy, S., Kharbanda, S., and Kufe, D. (2006) Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 AND MUC16. Gene 373, 28-34
36. Wreschner, D. H., McGuckin, M. A., Williams, S. J., Baruch, A., Yoeli, M., Ziv, R., Okun, L., Zaretsky, J., Smorodinsky, N., Keydar, I., Neophytou, P., Stacey, M., Lin, H. H., and Gordon, S. (2002) Generation of ligand-receptor alliances by "SEA" module-mediated cleavage of membrane-associated mucin proteins. Protein Sci. 11, 698-706
37. Fendrick, J. L., Konishi, I., Geary, S. M., Parmley, T. H., Quirk, J. G., Jr., and O'Brien, T. J. (1997) CA125 phosphorylation is associated with its secretion from the WISH human amnion cell line. Tumour Biol. 18, 278-289
38. Blalock, T. D., Spurr-Michaud, S. J., Tisdale, A. S., Heimer, S. R., Gilmore, M. S., Ramesh, V., and Gipson, I. K. (2007) Functions of MUC16 in corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 48, 4509-4518
39. Bafna, S., Kaur, S., and Batra, S. K. (2010) Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene 29, 2893-2904
40. Akita, K., Tanaka, M., Tanida, S., Mori, Y., Toda, M., and Nakada, H. (2013) CA125/MUC16 interacts with Src family kinases, and over-expression of its C-terminal fragment in human epithelial cancer cells reduces cell-cell adhesion. Eur. J. Cell Biol. 92, 257-263
41. Comamala, M., Pinard, M., Theriault, C., Matte, I., Albert, A., Boivin, M., Beaudin, J., Piche, A., and Rancourt, C. (2011) Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH: OVCAR3 ovarian carcinoma cells. Br. J. Cancer 104, 989-999
42. Lloyd, K. O., and Yin, B. W. (2001) Synthesis and secretion of the ovarian cancer antigen CA 125 by the human cancer cell line NIH: OVCAR-3. Tumour Biol. 22, 77-82
43. Davis, H. M., Zurawski, V. R., Jr., Bast, R. C., Jr., Klug, T. L. (1986) Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas. Cancer Res. 46, 6143-6148
44. Halila, H. (1985) Detection of ovarian cancer marker CA 125 in human seminal plasma. Tumour Biol. 6, 207-212
45. de los Frailes, M. T., Stark, S., Jaeger, W., Hoerauf, A., and Wildt, L. (1993) Purification and characterization of the CA 125 tumor-associated antigen from human ascites. Tumour Biol. 14, 18-29
46. Weiland, F., Fritz, K., Oehler, M. K., and Hoffmann, P. (2012) Methods for identification of CA125 from ovarian cancer ascites by high-resolution mass spectrometry. Int. J. Mol. Sci. 13, 9942-9958
47. Weiland, F., Martin, K., Oehler, M. K., and Hoffmann, P. (2012) Deciphering the molecular nature of ovarian cancer biomarker CA125. Int. J. Mol. Sci. 13, 10568-10582
48. Bennett, E. P., Mandel, U., Clausen, H., Gerken, T. A., Fritz, T. A., and Tabak, L. A. (2012) Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology 22, 736-756
49. Chen, K., Gentry-Maharaj, A., Burnell, M., Steentoft, C., Marcos- Silva, L., Mandel, U., Jacobs, I., Dawnay, A., Menon, U., and Blixt, O. (2013) Microarray glycoprofiling of CA125 improves differential diagnosis of ovarian cancer. J. Proteome Res. 12, 1408-1418
50. Yue, T., Goldstein, I. J., Hollingsworth, M. A., Kaul, K., Brand, R. E., and Haab, B. B. (2009) The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays. Mol. Cell. Proteomics 8, 1697-1707
51. Wu, Y. M., Nowack, D. D., Omenn, G. S., and Haab, B. B. (2009) Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells. J. Proteome Res. 8, 1876-1886
52. Campbell, I. G., Nicolai, H. M., Foulkes, W. D., Senger, G., Stamp, G. W., Allan, G., Boyer, C., Jones, K., Bast, R. C., Jr., and Solomon, E. (1994) A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1. Hum. Mol. Genet. 3, 589-594
53. Whitehouse, C., Chambers, J., Howe, K., Cobourne, M., Sharpe, P., and Solomon, E. (2002) NBR1 interacts with fasciculation and elongation protein zeta-1 (FEZ1) and calcium and integrin binding protein (CIB) and shows developmentally restricted expression in the neural tube. Eur. J. Biochem. 269, 538-545
54. Kutteh, W. H., Miller, D. S., and Mathis, J. M. (1996) Immunologic characterization of tumor markers in human ovarian cancer cell lines. J. Soc. Gynecol. Investig. 3, 216-222
55. Whitehouse, C., and Solomon, E. (2003) Current status of the molecular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening. Gynecol. Oncol. 88, S152-S157
56. Walinda, E., Morimoto, D., Sugase, K., Konuma, T., Tochio, H., and Shirakawa, M. (2014) Solution structure of the ubiquitin- associated (UBA) domain of human autophagy receptor NBR1 and its interaction with ubiquitin and polyubiquitin. J. Biol. Chem. 289, 13890-13902
57. Nustad, K., Lebedin, Y., Lloyd, K. O., Shigemasa, K., de Bruijn, H. W., Jansson, B., Nilsson, O., Olsen, K. H., O'Brien, T. J. (2002) Epitopes on CA 125 from cervical mucus and ascites fluid and characterization of six new antibodies. Third report from the ISOBM TD-1 workshop. Tumour Biol. 23, 303-314
58. Nustad, K., Bast, R. C., Jr., Brien, T. J., Nilsson, O., Seguin, P., Suresh, M. R., Saga, T., Nozawa, S., Bormer, O. P., de Bruijn, H. W., Nap, M., Vitali, A., Gadnell, M., Clark, J., Shigemasa, K., Karlsson, B., Kreutz, F. T., Jette, D., Sakahara, H., Endo, K., Paus, E., Warren, D., Hammarstrom, S., Kenemans, P., and Hilgers, J. (1996) Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. International Society for Oncodevelopmental Biology and Medicine. Tumour Biol. 17, 196-219
59. Davies, J. R., Kirkham, S., Svitacheva, N., Thornton, D. J., and Carlstedt, I. (2007) MUC16 is produced in tracheal surface epithelium and submucosal glands and is present in secretions from normal human airway and cultured bronchial epithelial cells. Int. J. Biochem. Cell Biol. 39, 1943-1954
60. Chen, Y., Clark, S., Wong, T., Chen, Y., Chen, Y., Dennis, M. S., Luis, E., Zhong, F., Bheddah, S., Koeppen, H., Gogineni, A., Ross, S., Polakis, P., and Mallet, W. (2007) Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor models. Cancer Res. 67, 4924-4932
61. Blalock, T. D., Spurr-Michaud, S. J., Tisdale, A. S., and Gipson, I. K. (2008) Release of membrane-associated mucins from ocular surface epithelia. Invest. Ophthalmol. Vis. Sci. 49, 1864-1871
62. Dharma, R. T., Park, K. J., Smith-Jones, P., Iasonos, A., Linkov, I., Soslow, R. A., and Spriggs, D. R. (2010) Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16. Appl. Immunohistochem. Mol. Morphol. 18, 462-472
63. Sumiyoshi, M., Ricciuto, J., Tisdale, A., Gipson, I. K., Mantelli, F., and Argueso, P. (2008) Antiadhesive character of mucin O-glycans at the apical surface of corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 49, 197-203
64. Kesimer, M., Scull, M., Brighton, B., DeMaria, G., Burns, K., O'Neal, W., Pickles, R. J., Sheehan, J. K. (2009) Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. FASEB J. 23, 1858-1868
65. Zeimet, A. G., Offner, F. A., Muller-Holzner, E., Widschwendter, M., Abendstein, B., Fuith, L. C., Daxenbichler, G., and Marth, C. (1998) Peritoneum and tissues of the female reproductive tract as physiological sources of CA-125. Tumour Biol. 19, 275-282
66. O'Brien, T. J., Hardin, J. W., Bannon, G. A., Norris, J. S., and Quirk, J. G. J. (1986) CA125 antigen in human amniotic fluid and fetal membranes. Am. J. Obstetr. Gynecol. 155, 50-55
67. Gipson, I. K. (2005) Human endocervical mucins. Ernst Schering Res. Found. Workshop 52, 219-244
68. Konishi, I., Fendrick, J. L., Parmley, T. H., Quirk, J. G., Jr., O'Brien, T. J. (1994) Epidermal growth factor enhances secretion of the ovarian tumor-associated cancer antigen CA125 from the human amnion WISH cell line. J. Soc. Gynecol. Investig. 1, 89-96
69. Inatomi, T., Spurr-Michaud, S., Tisdale, A. S., and Gipson, I. K. (1995) Human corneal and conjunctival epithelia express MUC1 mucin. Invest. Ophthalmol. Vis. Sci. 36, 1818-1827
70. Inatomi, T., Spurr-Michaud, S., Tisdale, A. S., Zhan, Q., Feldman, S. T., and Gipson, I. K. (1996) Expression of secretory mucin genes by human conjunctival epithelia. Invest. Ophthalmol. Vis. Sci. 37, 1684-1692
71. Spurr-Michaud, S., Argueso, P., and Gipson, I. (2007) Assay of mucins in human tear fluid. Exp. Eye Res. 84, 939-950
72. Jager, K., Wu, G., Sel, S., Garreis, F., Brauer, L., and Paulsen, F. P. (2007) MUC16 in the lacrimal apparatus. Histochem. Cell Biol. 127, 433-438
73. Argueso, P., Tisdale, A., Mandel, U., Letko, E., Foster, C. S., and Gipson, I. K. (2003) The cell-layer- and cell-type-specific distribution of GalNAc-transferases in the ocular surface epithelia is altered during keratinization. Invest. Ophthalmol. Vis. Sci. 44, 86-92
74. Mantelli, F., and Argueso, P. (2008) Functions of ocular surface mucins in health and disease. Curr. Opin. Allergy Clin. Immunol. 8, 477-483
75. Dogru, M., Matsumoto, Y., Okada, N., Igarashi, A., Fukagawa, K., Shimazaki, J., Tsubota, K., and Fujishima, H. (2008) Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis. Allergy 63, 1324-1334
76. Albertsmeyer, A. C., Kakkassery, V., Spurr-Michaud, S., Beeks, O., and Gipson, I. K. (2010) Effect of pro-inflammatory mediators on membrane-associated mucins expressed by human ocular surface epithelial cells. Exp. Eye Res. 90, 444-451
77. Hori, Y., Spurr-Michaud, S., Russo, C. L., Argueso, P., and Gipson, I. K. (2004) Differential regulation of membraneassociated mucins in the human ocular surface epithelium. Invest. Ophthalmol. Vis. Sci. 45, 114-122
78. Hori, Y., Spurr-Michaud, S. J., Russo, C. L., Argueso, P., and Gipson, I. K. (2005) Effect of retinoic acid on gene expression in human conjunctival epithelium: secretory phospholipase A2 mediates retinoic acid induction of MUC16. Invest. Ophthalmol. Vis. Sci. 46, 4050-4061
79. Lundgren, J. D., Shelhamer, J. H., and Kaliner, M. A. (1985) The role of eicosanoids in respiratory mucus hypersecretion. Ann. Allergy 55, 5-8, 11
80. Seo, K. Y., Chung, S. H., Lee, J. H., Park, M. Y., and Kim, E. K. (2007) Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. Cornea 26, 709-714
81. Argueso, P., Guzman-Aranguez, A., Mantelli, F., Cao, Z., Ricciuto, J., and Panjwani, N. (2009) Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier. J. Biol. Chem. 284, 23037-23045
82. Seelenmeyer, C., Wegehingel, S., Lechner, J., and Nickel, W. (2003) The cancer antigen CA125 represents a novel counter receptor for galectin-1. J. Cell Sci. 116, 1305-1318
83. Hovenberg, H. W., Davies, J. R., and Carlstedt, I. (1996) Different mucins are produced by the surface epithelium and the submucosa in human trachea: identification of MUC5AC as a major mucin from the goblet cells. Biochem. J. 318, 319-324
84. Wickstrom, C., Davies, J. R., Eriksen, G. V., Veerman, E. C., and Carlstedt, I. (1998) MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage. Biochem. J. 334, 685-693
85. Silverman, H. S., Sutton-Smith, M., Heal, P., Parry, S., Palmai- Pallag, T., Leir, S. H., Morris, H. R., Dell, A., and Harris, A. (2002) In vivo glycosylation of MUC1 in airway epithelial cells. Glycoconj. J. 19, 379-384
86. Woo, H. J., Bae, C. H., Song, S. Y., Lee, H. M., and Kim, Y. D. (2010) Expression of membrane-bound mucins in human nasal mucosa: different patterns for MUC4 and MUC16. Arch. Otolaryngol. Head Neck Surg. 136, 603-609
87. Ali, M., Lillehoj, E. P., Park, Y., Kyo, Y., and Kim, K. C. (2011) Analysis of the proteome of human airway epithelial secretions. Proteome Sci. 9, 4
88. Kesimer, M., Ehre, C., Burns, K. A., Davis, C. W., Sheehan, J. K., and Pickles, R. J. (2013) Molecular organization of the mucins and glycocalyx underlying mucus transport over mucosal surfaces of the airways. Mucosal Immunol. 6, 379-392
89. Bae, C. H., Kim, H. S., Song, S. Y., and Kim, Y. D. (2012) Phorbol 12-myristate 13-acetate induces MUC16 expression via PKCdelta and p38 in human airway epithelial cells. Clin. Exp. Otorhinolaryngol. 5, 161-169
90. Govindarajan, B., Menon, B. B., Spurr-Michaud, S., Rastogi, K., Gilmore, M. S., Argueso, P., and Gipson, I. K. (2012) A metalloproteinase secreted by Streptococcus pneumoniae removes membrane mucin MUC16 from the epithelial glycocalyx barrier. PLoS One 7, e32418
91. Gipson, I. K., Spurr-Michaud, S., Moccia, R., Zhan, Q., Toribara, N., Ho, S. B., Gargiulo, A. R., Hill, J. A., III (1999) MUC4 and MUC5B transcripts are the prevalent mucin messenger ribonucleic acids of the human endocervix. Biol. Reprod. 60, 58-64
92. Andersch-Bjorkman, Y., Thomsson, K. A., Holmen Larsson, J. M., Ekerhovd, E., and Hansson, G. C. (2007) Large-scale identification of proteins, mucins, and their O-glycosylation in the endocervical mucus during the menstrual cycle. Mol. Cell. Proteomics 6, 708-716
93. Mylonas, I., Makovitzky, J., Richter, D. U., Jeschke, U., Briese, V., and Friese, K. (2003) Immunohistochemical expression of the tumour marker CA-125 in normal, hyperplastic and malignant endometrial tissue. Anticancer Res. 23, 1075-1080
94. Martinez, A. R., Thomas, C. M., Segers, M. F., Schoemaker, J., and Eskes, T. K. (1994) CA-125 levels in cervical mucus during the menstrual cycle. Fertil. Steril. 61, 843-849
95. Vujisic, S., Kupesic, S., Mihaljevic, D., Aksamija, A., and Kurjak, A. (2002) Evaluation of serum CA 125 concentration before and during hormonal induced cycles as predictor of IVF/ ET outcome. Am. J. Reprod. Immunol. 48, 355-360
96. Sheng, Y. H., Hasnain, S. Z., Florin, T. H., and McGuckin, M. A. (2012) Mucins in inflammatory bowel diseases and colorectal cancer. J. Gastroenterol. Hepatol. 27, 28-38
97. Einerhand, A. W., Renes, I. B., Makkink, M. K., van der Sluis, M., Buller, H. A., and Dekker, J. (2002) Role of mucins in inflammatory bowel disease: important lessons from experimental models. Eur. J. Gastroenterol. Hepatol. 14, 757-765
98. Guimbaud, R., Bertrand, V., Chauvelot-Moachon, L., Quartier, G., Vidon, N., Giroud, J. P., Couturier, D., and Chaussade, S. (1998) Network of inflammatory cytokines and correlation with disease activity in ulcerative colitis. Am. J. Gastroenterol. 93, 2397-2404
99. Miralles, C., Orea, M., Espana, P., Provencio, M., Sanchez, A., Cantos, B., Cubedo, R., Carcereny, E., Bonilla, F., and Gea, T. (2003) Cancer antigen 125 associated with multiple benign and malignant pathologies. Ann. Surg. Oncol. 10, 150-154
100. Sikaris, K. A. (2011) CA125 - a test with a change of heart. Heart Lung Circ. 20, 634-640
101. Cwik, G., Wallner, G., Skoczylas, T., Ciechanski, A., and Zinkiewicz, K. (2006) Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. Arch. Surg. 141, 968-973
102. Cedres, S., Nunez, I., Longo, M., Martinez, P., Checa, E., Torrejon, D., and Felip, E. (2011) Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC). Clin. Lung Cancer 12, 172-179
103. Xue, X., Xue, Q., Wang, N., Zhang, L., Guo, L., Li, X., Sun, J., and Wang, J. (2012) Early clinical diagnosis of synchronous multiple primary lung cancer. Oncol. Lett. 3, 234-237
104. Higashi, M., Yamada, N., Yokoyama, S., Kitamoto, S., Tabata, K., Koriyama, C., Batra, S. K., and Yonezawa, S. (2012) Pathobiological implications of MUC16/CA125 expression in intrahepatic cholangiocarcinoma-mass forming type. Pathobiology 79, 101-106
105. Togami, S., Nomoto, M., Higashi, M., Goto, M., Yonezawa, S., Tsuji, T., Batra, S. K., and Douchi, T. (2010) Expression of mucin antigens (MUC1 and MUC16) as a prognostic factor for mucinous adenocarcinoma of the uterine cervix. J. Obstet. Gynaecol. Res. 36, 588-597
106. Streppel, M. M., Vincent, A., Mukherjee, R., Campbell, N. R., Chen, S. H., Konstantopoulos, K., Goggins, M. G., Van Seuningen, I., Maitra, A., and Montgomery, E. A. (2012) Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon. Hum. Pathol. 43, 1755-1763
107. Fujimura, T., Kinami, S., Ninomiya, I., Kitagawa, H., Fushida, S., Nishimura, G., Kayahara, M., Shimizu, K., Ohta, T., and Miwa, K. (2002) Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer. Endoscopy 34, 569-574
108. Chauhan, S. C., Singh, A. P., Ruiz, F., Johansson, S. L., Jain, M., Smith, L. M., Moniaux, N., and Batra, S. K. (2006) Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Mod. Pathol. 19, 1386-1394
109. Rump, A., Morikawa, Y., Tanaka, M., Minami, S., Umesaki, N., Takeuchi, M., and Miyajima, A. (2004) Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion. J. Biol. Chem. 279, 9190-9198
110. Gubbels, J. A., Belisle, J., Onda, M., Rancourt, C., Migneault, M., Ho, M., Bera, T. K., Connor, J., Sathyanarayana, B. K., Lee, B., Pastan, I., and Patankar, M. S. (2006) Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors. Mol. Cancer 5, 50
111. Kaneko, O., Gong, L., Zhang, J., Hansen, J. K., Hassan, R., Lee, B., and Ho, M. (2009) A binding domain on mesothelin for CA125/MUC16. J. Biol. Chem. 284, 3739-3749
112. Hassan, R., Ebel, W., Routhier, E. L., Patel, R., Kline, J. B., Zhang, J., Chao, Q., Jacob, S., Turchin, H., Gibbs, L., Phillips, M. D., Mudali, S., Iacobuzio-Donahue, C., Jaffee, E. M., Moreno, M., Pastan, I., Sass, P. M., Nicolaides, N. C., and Grasso, L. (2007) Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin. Cancer Immun. 7, 20
113. Patankar, M. S., Jing, Y., Morrison, J. C., Belisle, J. A., Lattanzio, F. A., Deng, Y., Wong, N. K., Morris, H. R., Dell, A., and Clark, G. F. (2005) Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125. Gynecol. Oncol. 99, 704-713
114. Boivin, M., Lane, D., Piche, A., and Rancourt, C. (2009) CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis. Gynecol. Oncol. 115, 407-413
115. Macdonald, F., Downing, R., and Allum, W. H. (1988) Expression of CA125 in pancreatic carcinoma and chronic pancreatitis. Br. J. Cancer 58, 505-506
116. Einama, T., Kamachi, H., Nishihara, H., Homma, S., Kanno, H., Takahashi, K., Sasaki, A., Tahara, M., Okada, K., Muraoka, S., Kamiyama, T., Matsuno, Y., Ozaki, M., and Todo, S. (2011) Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma. Pancreas 40, 1276-1282
117. Shimizu, A., Hirono, S., Tani, M., Kawai, M., Okada, K., Miyazawa, M., Kitahata, Y., Nakamura, Y., Noda, T., Yokoyama, S., and Yamaue, H. (2012) Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinoma. Cancer Sci. 103, 739-746
118. Chang, K., and Pastan, I. (1996) Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc. Natl. Acad. Sci. U. S. A. 93, 136-140
119. Chen, S. H., Hung, W. C., Wang, P., Paul, C., and Konstantopoulos, K. (2013) Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation. Sci. Rep. 3, 1870
120. Gebauer, F., Wicklein, D., Stubke, K., Nehmann, N., Schmidt, A., Salamon, J., Peldschus, K., Nentwich, M. F., Adam, G., Tolstonog, G., Bockhorn, M., Izbicki, J. R., Wagener, C., and Schumacher, U. (2013) Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in pfp-/rag2- mice. Gut 62, 741-750
121. Chen, S. H., Dallas, M. R., Balzer, E. M., and Konstantopoulos, K. (2012) Mucin 16 is a functional selectin ligand on pancreatic cancer cells. FASEB J. 26, 1349-1359
122. Radhakrishnan, P., Mohr, A. M., Grandgenett, P. M., Steele, M. M., Batra, S. K., and Hollingsworth, M. A. (2013) MicroRNA- 200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer. PLoS One 8, e73356
123. Moritani, S., Ichihara, S., Hasegawa, M., Endo, T., Oiwa, M., Yoshikawa, K., Sato, Y., Aoyama, H., Hayashi, T., and Kushima, R. (2008) Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis? Hum. Pathol. 39, 666-671
124. Tornos, C., Soslow, R., Chen, S., Akram, M., Hummer, A. J., Abu-Rustum, N., Norton, L., and Tan, L. K. (2005) Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am. J. Surg. Pathol. 29, 1482-1489
125. Lagendijk, J. H., Mullink, H., van Diest, P. J., Meijer, G. A., and Meijer, C. J. (1999) Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. J. Clin. Pathol. 52, 283-290
126. Reinartz, S., Failer, S., Schuell, T., and Wagner, U. (2012) CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells. Eur. J. Cancer 48, 1558-1569
127. Wang, Y., Cheon, D. J., Lu, Z., Cunningham, S. L., Chen, C. M., Luo, R. Z., Xing, D., Orsulic, S., Bast, R. C., Jr., and Behringer, R. R. (2008) MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse. Differentiation 76, 1081-1092
128. Cheon, D. J., Wang, Y., Deng, J. M., Lu, Z., Xiao, L., Chen, C. M., Bast, R. C., and Behringer, R. R. (2009) CA125/MUC16 is dispensable for mouse development and reproduction. PLoS One 4, e4675
129. Siegel, R., Naishadham, D., and Jemal, A. (2013) Cancer statistics, 2013. CA Cancer J. Clin. 63, 11-30
130. Geng, X. F., Du, M., Han, J. X., Zhang, M., Tang, X. F., and Xing, R. D. (2013) Saliva CA125 and TPS levels in patients with oral squamous cell carcinoma. Int. J. Biol. Markers 28, 216-220
131. Bischof, P. (1993) What do we know about the origin of CA 125? Eur. J. Obstet. Gynecol. Reprod. Biol. 49, 93-98
132. Yu, D., Du, K., Liu, T., and Chen, G. (2013) Prognostic value of tumor markers, NSE, CA125 and SCC, in operable NSCLC patients. Int. J. Mol. Sci. 14, 11145-11156
133. He, C. Z., Zhang, K. H., Li, Q., Liu, X. H., Hong, Y., and Lv, N. H. (2013) Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer. BMC Gastroenterol. 13, 87
134. Devarbhavi, H., Kaese, D., Williams, A. W., Rakela, J., Klee, G. G., and Kamath, P. S. (2002) Cancer antigen 125 in patients with chronic liver disease. Mayo Clin. Proc. 77, 538-541
135. Molina, R., Filella, X., Bruix, J., Mengual, P., Bosch, J., Calvet, X., Jo, J., and Ballesta, A. M. (1991) Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases. Clin. Chem. 37, 1379-1383
136. Chaube, A., Tewari, M., Singh, U., and Shukla, H. S. (2006) CA 125: a potential tumor marker for gallbladder cancer. J. Surg. Oncol. 93, 665-669
137. Shukla, V. K., Gurubachan, Sharma, D., Dixit, V. K., and Usha (2006) Diagnostic value of serum CA242, CA 19-9, CA 15-3 and CA 125 in patients with carcinoma of the gallbladder. Trop. Gastroenterol. 27, 160-165
138. Antonsen, S. L., Hogdall, E., Christensen, I. J., Lydolph, M., Tabor, A., Loft, J. A., Fago-Olsen, C. L., Andersen, E. S., Jochumsen, K., and Hogdall, C. (2013) HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET). Acta Obstet. Gynecol. Scand. 92, 1313-1322